Search Results - "de Seze, Jérôme"

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis by Montalban, Xavier, Hauser, Stephen L, Kappos, Ludwig, Arnold, Douglas L, Bar-Or, Amit, Comi, Giancarlo, de Seze, Jérôme, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Rammohan, Kottil W, Selmaj, Krzysztof, Traboulsee, Anthony, Sauter, Annette, Masterman, Donna, Fontoura, Paulo, Belachew, Shibeshih, Garren, Hideki, Mairon, Nicole, Chin, Peter, Wolinsky, Jerry S

“…Patients with primary progressive MS who received the anti-CD20+ humanized antibody ocrelizumab were less likely to have clinical deterioration that was…”
Get full text

Emotional experience is increased and emotion recognition decreased in multiple sclerosis by Pfaff, Line, Gounot, Daniel, Chanson, Jean-Baptiste, de Seze, Jérôme, Blanc, Frédéric

“…Emotional disorders in multiple sclerosis (MS) are frequently described as difficulties in recognizing facial expressions, rarely in the experience dimension…”
Get full text

Radiologically isolated syndrome: 5-year risk for an initial clinical event by Okuda, Darin T, Siva, Aksel, Kantarci, Orhun, Inglese, Matilde, Katz, Ilana, Tutuncu, Melih, Keegan, B Mark, Donlon, Stacy, Hua, Le H, Vidal-Jordana, Angela, Montalban, Xavier, Rovira, Alex, Tintoré, Mar, Amato, Maria Pia, Brochet, Bruno, de Seze, Jérôme, Brassat, David, Vermersch, Patrick, De Stefano, Nicola, Sormani, Maria Pia, Pelletier, Daniel, Lebrun, Christine

“…To report the 5-year risk and to identify risk factors for the development of a seminal acute or progressive clinical event in a multi-national cohort of…”
Get full text

Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy by KLEBE, Stephan, DEPIENNE, Christel, DOLLFUS, Hélène, CHINNERY, Patrick F, MANCINI, Cecilia, FERRER, Xavier, SOLE, Guilhem, DESTEE, Alain, MAYER, Jean-Michel, FONTAINE, Bertrand, DE SEZE, Jerome, CLANET, Michel, GERBER, Sylvie, OLLAGNON, Elisabeth, BUSSON, Philippe, CAZENEUVE, Cécile, STEVANIN, Giovanni, KAPLAN, Josseline, ROZET, Jean-Michel, BRICE, Alexis, DURR, Alexandra, CHALLE, Georges, ANHEIM, Mathieu, CHARLES, Perrine, FEDIRKO, Estelle, LEJEUNE, Elodie, COTTINEAU, Julien, BRUSCO, Alfredo

“…Mutations in the spastic paraplegia 7 (SPG7) gene encoding paraplegin are responsible for autosomal recessive hereditary spasticity. We screened 135 unrelated…”
Get full text

Good therapeutic response to infliximab in a case of Susac syndrome refractory to immunotherapies including tocilizumab by Demuth, Stanislas, Bogdan, Thomas, Kremer, Laurent, Lanotte, Livia, Collongues, Nicolas, de Seze, Jérôme, Bigaut, Kévin

Get full text

Quantitative and qualitative normative dataset for intraepidermal nerve fibers using skin biopsy by Collongues, Nicolas, Samama, Brigitte, Schmidt-Mutter, Catherine, Chamard-Witkowski, Ludivine, Debouverie, Marc, Chanson, Jean-Baptiste, Antal, Maria-Cristina, Benardais, Karelle, de Seze, Jérôme, Velten, Michel, Boehm, Nelly

“…Skin biopsy is the most relevant tool to diagnose small-fiber neuropathy. A well-documented normal dataset for intraepidermal nerve fiber in the distal leg is…”
Get full text

Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study by Bigaut, Kévin, Kremer, Laurent, Fabacher, Thibaut, Ahle, Guido, Goudot, Mathilde, Fleury, Marie, Gaultier, Claude, Courtois, Sylvie, Collongues, Nicolas, de Seze, Jérôme

“…Background Exit strategy after natalizumab cessation in multiple sclerosis (MS) is a crucial point because the risk of disease reactivation is high during this…”
Get full text

FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis by Kremer, Laurent, Taleb, Omar, Boehm, Nelly, Mensah-Nyagan, Ayikoe Guy, Trifilieff, Elisabeth, de Seze, Jérôme, Brun, Susana

“…Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune-mediated inflammatory disease of the peripheral nervous system characterized…”
Get full text

Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study by Cohen, Mikael, Thomel-Rocchi, Océane, Siva, Aksel, Okuda, Darin T, Karabudak, Rana, Efendi, Hüsnü, Terzi, Murat, Carra-Dalliere, Clarisse, Durand-Dubief, Francoise, Thouvenot, Eric, Ciron, Jonathan, Zephir, Helene, Bourre, Bertrand, Casez, Olivier, De Seze, Jérôme, Moreau, Thibault, Neau, Jean-Philippe, Pelletier, Daniel, Kantarci, Orhun, Tutuncu, Melih, Derache, Nathalie, Bensa, Caroline, Louapre, Celine, Benoit, Jeanne, Landes-Chateau, Cassandre, Lebrun-Frenay, Christine

“…Background: Vaccination in patients with multiple sclerosis (MS) treated with immunosuppressive drugs is highly recommended. Regarding COVID-19 vaccination, no…”
Get full text

Frequency of myelin oligodendrocyte glycoprotein antibody in multiple sclerosis: A multicenter cross-sectional study by Cobo-Calvo, Álvaro, d'Indy, Hyacintha, Ruiz, Anne, Collongues, Nicolas, Kremer, Laurent, Durand-Dubief, Françoise, Rollot, Fabien, Casey, Romain, Vukusic, Sandra, De Seze, Jérôme, Marignier, Romain

“…To address the frequency of myelin oligodendrocyte glycoprotein (MOG) antibody (Ab) in an unselected large cohort of adults with MS. This is a cross-sectional…”
Get full text

Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis optica by Januel, Edouard, De Seze, Jérôme, Vermersch, Patrick, Maillart, Elisabeth, Bourre, Bertrand, Pique, Julie, Moisset, Xavier, Bensa, Caroline, Maarouf, Adil, Pelletier, Jean, Vukusic, Sandra, Audoin, Bertrand, Louapre, Céline, Beltran, Stéphane, Berger, Eric, Bigaut, Kevin, Derache, Nathalie, Gassama, Salimata, Heinzlef, Olivier, Kremer, Laurent, Kerschen, Philippe, Maurousset, Aude, Ricigliano, Vito A G, Garcia, Pierre-Yves, Labauge, Pierre

“…Introduction: Recent studies suggested that anti-CD20 and fingolimod may be associated with lower anti-spike protein-based immunoglobulin-G response following…”
Get full text

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study by Barbin, Laetitia, Rousseau, Chloe, Jousset, Natacha, Casey, Romain, Debouverie, Marc, Vukusic, Sandra, De Sèze, Jerome, Brassat, David, Wiertlewski, Sandrine, Brochet, Bruno, Pelletier, Jean, Vermersch, Patrick, Edan, Gilles, Lebrun-Frenay, Christine, Clavelou, Pierre, Thouvenot, Eric, Camdessanché, Jean-Philippe, Tourbah, Ayman, Stankoff, Bruno, Al Khedr, Abdullatif, Cabre, Philippe, Papeix, Caroline, Berger, Eric, Heinzlef, Olivier, Debroucker, Thomas, Moreau, Thibault, Gout, Olivier, Bourre, Bertrand, Créange, Alain, Labauge, Pierre, Magy, Laurent, Defer, Gilles, Foucher, Yohann, Laplaud, David A

“…To compare natalizumab and fingolimod on both clinical and MRI outcomes in patients with relapsing-remitting multiple sclerosis (RRMS) from 27 multiple…”
Get full text

Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort by Bigaut, Kévin, Fabacher, Thibaut, Kremer, Laurent, Ongagna, Jean-Claude, Kwiatkowski, Arnaud, Sellal, François, Ferriby, Didier, Courtois, Sylvie, Vermersch, Patrick, Collongues, Nicolas, Zéphir, Hélène, De Seze, Jérôme, Outteryck, Olivier

“…Background: Data are needed on long-term effect of natalizumab (NTZ) in relapsing-remitting multiple sclerosis (RRMS). Objectives: To evaluate the time of…”
Get full text

The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis by Leva, Géraldine, Klein, Christian, Benyounes, Jérémie, Hallé, François, Bihel, Frédéric, Collongues, Nicolas, De Seze, Jérôme, Mensah-Nyagan, Ayikoe-Guy, Patte-Mensah, Christine

“…Multiple sclerosis (MS) is a severe autoimmune disease characterized by inflammatory, demyelinating and neurodegenerative components causing motor, sensory,…”
Get full text

Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis by Mathais, Sophie, Moisset, Xavier, Pereira, Bruno, Taithe, Frédéric, Ciron, Jonathan, Labauge, Pierre, Dulau, Cécile, Laplaud, David, De Seze, Jérôme, Pelletier, Jean, Berger, Eric, Lebrun-Frenay, Christine, Castelnovo, Giovanni, Edan, Gilles, Defer, Gilles, Vermersch, Patrick, Bourre, Bertrand, Camdessanche, Jean-Philippe, Magy, Laurent, Guennoc, Anne-Marie, Mathey, Guillaume, Moreau, Thibault, Gout, Olivier, Heinzlef, Olivier, Maillart, Elisabeth, Vukusic, Sandra, Clavelou, Pierre

“…High-dose biotin (HDB) is a therapy used in non-active progressive multiple sclerosis (PMS). Several reports have suggested that HDB treatment may be…”
Get full text

BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS by Cohen, Mikael, Mondot, Lydiane, Bucciarelli, Florence, Pignolet, Béatrice, Laplaud, David-Axel, Wiertlewski, Sandrine, Brochet, Bruno, Ruet, Aurélie, Defer, Gilles, Derache, Nathalie, Vermersch, Patrick, Zephir, Hélène, Debouverie, Marc, Mathey, Guillaume, Berger, Eric, Cappé, Chrystelle, Labauge, Pierre, Carra, Clarisse, De Seze, Jérôme, Bigaut, Kevin, Brassat, David, Lebrun-Frenay, Christine

“…Background: There are few head-to-head studies to compare highly active treatments in multiple sclerosis (MS) Objective: The aim of this study was to compare…”
Get full text

Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS study by Vukusic, Sandra, Ionescu, Iuliana, Cornu, Catherine, Bossard, Nadine, Durand-Dubief, Françoise, Cotton, François, Durelli, Luca, Marignier, Romain, Gignoux, Laurence, Laplaud, David-Axel, Moreau, Thibault, Clavelou, Pierre, De Seze, Jérôme, Debouverie, Marc, Brassat, David, Pelletier, Jean, Lebrun-Frenay, Christine, Le Page, Emmanuelle, Castelnovo, Giovanni, Berger, Eric, Hautecoeur, Patrick, Heinzlef, Olivier, Trojano, Maria, Patti, Francesco, Baulieu, Etienne-Emile, Remontet, Laurent, El-Etr, Martine

“…Background: Sex steroids could explain the course of multiple sclerosis (MS) in pregnancy. Objective: To compare the annualized relapse rate (ARR) 12 weeks…”
Get full text

Focal and diffuse cervical spinal cord damage in patients with early relapsing–remitting MS: A multicentre magnetisation transfer ratio study by Combès, Benoît, Kerbrat, Anne, Ferré, Jean Christophe, Callot, Virginie, Maranzano, Josefina, Badji, Atef, Le Page, Emmanuelle, Labauge, Pierre, Ayrignac, Xavier, Carra Dallière, Clarisse, de Champfleur, Nicolas Menjot, Pelletier, Jean, Maarouf, Adil, de Seze, Jérôme, Collongues, Nicolas, Brassat, David, Durand-Dubief, Françoise, Barillot, Christian, Bannier, Elise, Edan, Gilles

“…Background: Studies including patients with well-established multiple sclerosis (MS) have shown a significant and disability-related reduction in the cervical…”
Get full text

Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML by Alleg, Manel, Solis, Morgane, Baloglu, Seyyid, Cotton, François, Kerschen, Philippe, Bourre, Bertrand, Ahle, Guido, Pruvo, Jean-Pierre, Leclerc, Xavier, Vermersch, Patrick, Papeix, Caroline, Maillart, Élisabeth, Houillier, Caroline, Chabrot, Cécile Moluçon, Claise, Béatrice, Malak, Sandra, Martin-Blondel, Guillaume, Bonneville, Fabrice, Caulier, Alexis, Marolleau, Jean-Pierre, Bonnefoy, Jérôme Tamburini, Agape, Philippe, Kennel, Céline, Roussel, Xavier, Chauchet, Adrien, De Seze, Jérôme, Fafi-Kremer, Samira, Kremer, Stéphane

“…Objectives To compare brain MRI findings in progressive multifocal leukoencephalopathy (PML) associated to rituximab and natalizumab treatments and HIV…”
Get full text

Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement by Bordet, Régis, Camu, William, De Seze, Jérôme, Laplaud, David-Axel, Ouallet, Jean-Christophe, Thouvenot, Eric

“…The ideal treatment for multiple sclerosis (MS) would target both the neuroinflammatory component of the disease (peripheral and central) and its…”
Get full text